SNY even got rid of Aventis part of name with ambition to become a household name in China. A couple of years [CEO Chirs Viehbacher] talked about the Chinese translation of Sanofi Aventis is too long to become a household name in China.
“The notion that there’s a Chinese Wall between sell-side analysts and investment bankers may be the second-biggest piece of BS ever promulgated in any area of human knowledge!”